Pharmaceutical composition

Details Pharmaceutical composition Pharmaceutical composition

1995-01-17

1997-08-05

Kight, John

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Carbohydrate doai

536117, A61K 3170, C07H 1104, C07H 1300

Patent

active

056542801

ABSTRACT:
A pharmaceutical composition comprising a pharmaceutically active ingredient selected from the group consisting of trisphosphorylated pentoses, pentitols or anhydropentitols, trisphosphorylated hexoses, hexitols or anhydrohexitols and trisphosphorylated heptoses, heptitols or anhydroheptitols. The active ingredient can also be present in the form of a salt. The invention also includes a method of preventing or alleviating tissue damage in mammals, including man. The method comprises administering an effective amount of the pharmaceutical composition.

REFERENCES:
patent: 3408257 (1968-10-01), Kawamori et al.
patent: 3931402 (1976-01-01), Ghielmetti et al.
patent: 4444780 (1984-04-01), Capetola et al.
patent: 4448771 (1984-05-01), Cattani et al.
patent: 4745185 (1988-05-01), Maryanoff et al.
patent: 4793945 (1988-12-01), Siren
patent: 4968790 (1990-11-01), DeVries et al.
patent: 5015634 (1991-05-01), Siren
Tener et al, "Phosphorylated Sugars. VI. Syntheses of .alpha.-D-Ribofuranose 1,5-Diphosphate and .alpha.-D-Ribofuranose 1-Pyrophosphate 5-Phosphate" published 1958, pp. 1999-2004.
PCT/SE90/000843, International Search Report, Perstorp AB et al. 4 pages.

Affiliated with

Also associated with

Rating

Pharmaceutical composition does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pharmaceutical composition, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical composition will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1074857